Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care cybersecurity following major attacks.